Skip to main content
Clinical Trials/NL-OMON54267
NL-OMON54267
Recruiting
Phase 3

Dupuytren*s disease Evaluation of Preventative or Adjuvant Radiation Therapy - DEPART-trial

GenesisCare Cancer Care Research Pty Ltd0 sites100 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Dupuytren's disease
Sponsor
GenesisCare Cancer Care Research Pty Ltd
Enrollment
100
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
GenesisCare Cancer Care Research Pty Ltd

Eligibility Criteria

Inclusion Criteria

  • Prevention cohort
  • Evidence of nodules and/or cords in the affected hand consistent with DD
  • History of progressive DD over previous 6 months
  • No previous radiotherapy to the affected hand
  • No history of radiation sensitivity diseases (eg Scleroderma, Ataxia
  • Telangiectasia, Li Fraumeni)
  • No previous SF, NA or CI in the affected hand
  • Absence of flexion contractures: Passive extension deficit (PED) must be less
  • than, or equal to, 10 degrees (\<\=10°) in any joints of the affected hand.
  • Patient Consent

Exclusion Criteria

  • Prevention cohort
  • No evidence of nodules and/or cords in the affected hand consistent with DD
  • No history of progressive DD over previous 6 months
  • Previous radiotherapy to the affected hand
  • History of radiation sensitivity diseases (eg Scleroderma, Ataxia
  • Telangiectasia, Li Fraumeni)
  • Previous SF, NA or CI in the affected hand
  • Prescence of flexion contractures: Passive flexion contracture greater than
  • 10 degrees (\>10°) in all joints of the affected hand.
  • Age \<\= 30

Outcomes

Primary Outcomes

Not specified

Similar Trials